These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32 related articles for article (PubMed ID: 33336793)
1. Primary cutaneous CD8 Wei R; Wang H; Zhang J; Zhang Z; Yao Z Int J Dermatol; 2024 May; 63(5):660-663. PubMed ID: 38263572 [No Abstract] [Full Text] [Related]
2. Chronic Radiation Dermatitis Secondary to Narrow-Band Ultraviolet B Therapy in a Patient With Primary Cutaneous CD8 + T-Cell Lymphoma With Cytotoxic Granules. Edelson MP; Gay JJ; Thiel RW; Grider DJ Am J Dermatopathol; 2024 May; 46(5):312-315. PubMed ID: 38513130 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of high-dose methotrexate completion for primary central nervous system lymphoma using modified Geriatric 8 for functional assessment: A retrospective descriptive study. Matsunuma S; Koshiishi T; Sunaga S; Otsuka K; Okumura E; Yoshimoto K; Jimbo H J Geriatr Oncol; 2024 Apr; 15(3):101704. PubMed ID: 38245426 [No Abstract] [Full Text] [Related]
4. A very rare complication of subdural haematoma: fibrin-associated diffuse large B-cell lymphoma. Bitar G; Chau I; Wotherspoon A; El-Sharkawi D; Iyengar S; Sharma B Br J Haematol; 2021 Mar; 192(6):947. PubMed ID: 33336795 [No Abstract] [Full Text] [Related]
5. Durable remission of a patient with primary cutaneous CD8 Al Aoun SM; Iqbal S; AlHalouli TM; Zaidi SZ; Motabi IH Hematol Oncol Stem Cell Ther; 2021 Mar; 14(1):71-75. PubMed ID: 30291826 [TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma? Gomez Vazquez M; Navarra Amayuelas R Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522 [TBL] [Abstract][Full Text] [Related]
7. Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma. Morse DC; Park KE; Chitsazzadeh V; Li S; Young K; Gunther JR; Dabaja BS; Duvic M Int J Gynecol Pathol; 2021 May; 40(3):229-233. PubMed ID: 33741766 [TBL] [Abstract][Full Text] [Related]
8. [Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma: report of one case]. Intriago B M; Peña O C; Gray H AM; Cabrera C ME; Martínez C V Rev Med Chil; 2012 Mar; 140(3):368-72. PubMed ID: 22689119 [TBL] [Abstract][Full Text] [Related]
9. CD4/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma? Miyauchi T; Abe R; Morita Y; Adachi M; Shiba K; Hamade Y; Saito N; Nishimura M; Ibata M; Okada K; Shigematsu A; Endo T; Kawai K; Teshima T; Shimizu H Acta Derm Venereol; 2015 Nov; 95(8):1024-5. PubMed ID: 25792011 [No Abstract] [Full Text] [Related]
10. Central nervous system relapse of primary cutaneous CD8 Oun H; Wilson M; Leach M; McKay P Br J Haematol; 2021 Apr; 193(1):9. PubMed ID: 33336793 [No Abstract] [Full Text] [Related]
11. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation. Nofal A; Abdel-Mawla MY; Assaf M; Salah E J Am Acad Dermatol; 2012 Oct; 67(4):748-59. PubMed ID: 22226429 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic management of refractory or relapsed primary central nervous system lymphomas. Reni M; Ferreri AJ Ann Hematol; 2001; 80 Suppl 3():B113-7. PubMed ID: 11757691 [TBL] [Abstract][Full Text] [Related]